Plavix Generic Faces Injunction, But Not Recall
This article was originally published in The Pink Sheet Daily
Executive Summary
Apotex is filing emergency appeal to stay the injunction after Bristol and Sanofi win in U.S. district court.
You may also be interested in...
Bristol May Have Grounds For Fraud Case Against Apotex – Attorney
Wiley Rein & Fielding partner says Bristol-Myers Squibb may have a case against Apotex for sabotaging the Plavix settlement deal.
Bristol May Have Grounds For Fraud Case Against Apotex – Attorney
Wiley Rein & Fielding partner says Bristol-Myers Squibb may have a case against Apotex for sabotaging the Plavix settlement deal.
Plavix Patent Infringement Trial Set For Jan. 22
Sanofi/Bristol demonstrated that Apotex patent invalidity defense "lacks substantial merit," according to a court ruling granting a preliminary injunction blocking generics.